Optimal Vasopressin Initiation in Septic Shock: The OVISS Reinforcement Learning Study

Area of Science:

• Critical Care Medicine
• Pharmacology
• Artificial Intelligence in Healthcare

Background:

• Norepinephrine is the primary vasopressor for septic shock.
• Optimal timing and use of adjunctive vasopressors like vasopressin remain unclear.

Purpose of the Study:

• To develop and validate a reinforcement learning (RL) model for optimal vasopressin initiation in adult septic shock patients.
• To improve patient outcomes by defining a data-driven vasopressin administration strategy.

Main Methods:

• Reinforcement learning model derived from electronic health record data (3608 patients).
• Model validated on large, multi-center datasets (10,217 patients) using weighted importance sampling.
• Comparison of RL-guided vasopressin initiation versus clinician practices.

Main Results:

• The RL model recommended earlier (4 vs 5 hours) and more frequent (87% vs 31%) vasopressin initiation at lower norepinephrine doses.
• The RL-guided strategy demonstrated a larger expected reward compared to clinician actions.
• Association of RL-guided vasopressin initiation with significantly lower in-hospital mortality (OR, 0.81).

Conclusions:

• A reinforcement learning model provides an optimal rule for vasopressin initiation in septic shock.
• The model suggests more liberal and earlier vasopressin use than current practices.
• This data-driven approach is associated with improved survival in critically ill patients.